US Stock MarketDetailed Quotes

AGIO Agios Pharmaceuticals

Watchlist

55.335
-0.205-0.37%

Trading Nov 22 10:44 ET

3.16BMarket Cap4.75P/E (TTM)

Agios Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

21.15%8.96M

28.35%8.62M

46.00%8.19M

88.36%26.82M

64.80%7.1M

110.44%7.4M

20.24%6.71M

574.16%5.61M

14.24M

4.31M

Operating revenue

21.15%8.96M

28.35%8.62M

46.00%8.19M

88.36%26.82M

64.80%7.1M

110.44%7.4M

20.24%6.71M

574.16%5.61M

--14.24M

--4.31M

Cost of revenue

23.70%783K

34.93%1.5M

13.18%627K

69.07%2.88M

41.89%586K

22.44%633K

154.71%1.11M

63.42%554K

1.7M

413K

Gross profit

20.91%8.18M

27.05%7.12M

49.59%7.56M

90.99%23.94M

67.23%6.52M

125.61%6.77M

8.88%5.6M

925.35%5.06M

12.54M

3.9M

Operating expense

3.09%110.99M

13.73%112.94M

4.15%99.63M

3.45%415.43M

9.44%112.79M

14.43%107.66M

-3.39%99.3M

-5.87%95.67M

6.12%401.58M

-1.68%103.07M

Selling and administrative expenses

49.24%38.54M

16.86%35.54M

9.33%31.01M

-1.45%119.9M

7.73%35.31M

-11.33%25.82M

7.59%30.41M

-9.99%28.37M

0.19%121.67M

3.94%32.77M

Research and development costs

-11.47%72.46M

12.35%77.4M

1.96%68.62M

5.58%295.53M

10.23%77.49M

25.98%81.84M

-7.55%68.9M

-4.02%67.3M

8.93%279.91M

-4.09%70.3M

Operating profit

-1.90%-102.81M

-12.93%-105.82M

-1.61%-92.07M

-0.63%-391.49M

-7.16%-106.28M

-10.77%-100.9M

4.04%-93.7M

10.41%-90.61M

-2.81%-389.05M

5.39%-99.17M

Net non-operating interest income expense

55.93%13.06M

-1.62%8.12M

9.86%8.89M

160.64%33.34M

32.92%8.62M

119.36%8.38M

360.35%8.25M

1,065.85%8.09M

1,430.26%12.79M

1,854.22%6.49M

Non-operating interest income

55.93%13.06M

-1.62%8.12M

9.86%8.89M

160.64%33.34M

32.92%8.62M

119.36%8.38M

360.35%8.25M

1,065.85%8.09M

1,430.26%12.79M

1,854.22%6.49M

Other net income (expense)

90,950.67%1.09B

-3.72%1.58M

8.64%1.63M

-95.81%6.06M

-98.67%1.71M

-78.32%1.2M

-59.42%1.64M

-73.51%1.5M

585.52%144.45M

2,085.92%129.21M

Special income (charges)

--1.09B

----

--0

----

1,974.17%137.7M

4,737.42%127.85M

-Gain on sale of business

--1.09B

----

--0

----

1,974.17%137.7M

4,737.42%127.85M

Other non- operating income (expenses)

37.81%1.65M

-3.72%1.58M

8.64%1.63M

-10.28%6.06M

26.23%1.71M

10.72%1.2M

22.66%1.64M

-49.41%1.5M

-53.24%6.75M

-58.48%1.36M

Income before tax

1,196.14%1B

-14.69%-96.12M

-0.66%-81.55M

-51.89%-352.09M

-362.66%-95.94M

-11.72%-91.32M

8.71%-83.81M

14.51%-81.02M

34.98%-231.8M

137.05%36.53M

Income tax

53.12M

Net income

1,137.97%947.92M

-14.69%-96.12M

-0.66%-81.55M

-51.89%-352.09M

-362.66%-95.94M

-11.72%-91.32M

8.71%-83.81M

14.51%-81.02M

-114.44%-231.8M

138.60%36.53M

Net income continuous Operations

1,137.97%947.92M

-14.69%-96.12M

-0.66%-81.55M

-51.89%-352.09M

-362.66%-95.94M

-11.72%-91.32M

8.71%-83.81M

14.51%-81.02M

34.98%-231.8M

137.05%36.53M

Net income discontinuous operations

----

--0

----

--0

----

Minority interest income

Net income attributable to the parent company

1,137.97%947.92M

-14.69%-96.12M

-0.66%-81.55M

-51.89%-352.09M

-362.66%-95.94M

-11.72%-91.32M

8.71%-83.81M

14.51%-81.02M

-114.44%-231.8M

138.60%36.53M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

1,137.97%947.92M

-14.69%-96.12M

-0.66%-81.55M

-51.89%-352.09M

-362.66%-95.94M

-11.72%-91.32M

8.71%-83.81M

14.51%-81.02M

-114.44%-231.8M

138.60%36.53M

Basic earnings per share

1,115.24%16.65

-11.92%-1.69

1.36%-1.45

-49.65%-6.33

-356.72%-1.72

-10.07%-1.64

10.12%-1.51

15.52%-1.47

-115.93%-4.23

138.51%0.67

Diluted earnings per share

1,089.02%16.22

-11.92%-1.69

1.36%-1.45

-49.65%-6.33

-356.72%-1.72

-10.07%-1.64

10.12%-1.51

15.52%-1.47

-115.93%-4.23

138.51%0.67

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	21.15%8.96M	28.35%8.62M	46.00%8.19M	88.36%26.82M	64.80%7.1M	110.44%7.4M	20.24%6.71M	574.16%5.61M	14.24M	4.31M
Operating revenue	21.15%8.96M	28.35%8.62M	46.00%8.19M	88.36%26.82M	64.80%7.1M	110.44%7.4M	20.24%6.71M	574.16%5.61M	--14.24M	--4.31M
Cost of revenue	23.70%783K	34.93%1.5M	13.18%627K	69.07%2.88M	41.89%586K	22.44%633K	154.71%1.11M	63.42%554K	1.7M	413K
Gross profit	20.91%8.18M	27.05%7.12M	49.59%7.56M	90.99%23.94M	67.23%6.52M	125.61%6.77M	8.88%5.6M	925.35%5.06M	12.54M	3.9M
Operating expense	3.09%110.99M	13.73%112.94M	4.15%99.63M	3.45%415.43M	9.44%112.79M	14.43%107.66M	-3.39%99.3M	-5.87%95.67M	6.12%401.58M	-1.68%103.07M
Selling and administrative expenses	49.24%38.54M	16.86%35.54M	9.33%31.01M	-1.45%119.9M	7.73%35.31M	-11.33%25.82M	7.59%30.41M	-9.99%28.37M	0.19%121.67M	3.94%32.77M
Research and development costs	-11.47%72.46M	12.35%77.4M	1.96%68.62M	5.58%295.53M	10.23%77.49M	25.98%81.84M	-7.55%68.9M	-4.02%67.3M	8.93%279.91M	-4.09%70.3M
Operating profit	-1.90%-102.81M	-12.93%-105.82M	-1.61%-92.07M	-0.63%-391.49M	-7.16%-106.28M	-10.77%-100.9M	4.04%-93.7M	10.41%-90.61M	-2.81%-389.05M	5.39%-99.17M
Net non-operating interest income expense	55.93%13.06M	-1.62%8.12M	9.86%8.89M	160.64%33.34M	32.92%8.62M	119.36%8.38M	360.35%8.25M	1,065.85%8.09M	1,430.26%12.79M	1,854.22%6.49M
Non-operating interest income	55.93%13.06M	-1.62%8.12M	9.86%8.89M	160.64%33.34M	32.92%8.62M	119.36%8.38M	360.35%8.25M	1,065.85%8.09M	1,430.26%12.79M	1,854.22%6.49M
Other net income (expense)	90,950.67%1.09B	-3.72%1.58M	8.64%1.63M	-95.81%6.06M	-98.67%1.71M	-78.32%1.2M	-59.42%1.64M	-73.51%1.5M	585.52%144.45M	2,085.92%129.21M
Special income (charges)	--1.09B	----	----	--0	--0	--0	----	----	1,974.17%137.7M	4,737.42%127.85M
-Gain on sale of business	--1.09B	----	----	--0	--0	--0	----	----	1,974.17%137.7M	4,737.42%127.85M
Other non- operating income (expenses)	37.81%1.65M	-3.72%1.58M	8.64%1.63M	-10.28%6.06M	26.23%1.71M	10.72%1.2M	22.66%1.64M	-49.41%1.5M	-53.24%6.75M	-58.48%1.36M
Income before tax	1,196.14%1B	-14.69%-96.12M	-0.66%-81.55M	-51.89%-352.09M	-362.66%-95.94M	-11.72%-91.32M	8.71%-83.81M	14.51%-81.02M	34.98%-231.8M	137.05%36.53M
Income tax	53.12M					0
Net income	1,137.97%947.92M	-14.69%-96.12M	-0.66%-81.55M	-51.89%-352.09M	-362.66%-95.94M	-11.72%-91.32M	8.71%-83.81M	14.51%-81.02M	-114.44%-231.8M	138.60%36.53M
Net income continuous Operations	1,137.97%947.92M	-14.69%-96.12M	-0.66%-81.55M	-51.89%-352.09M	-362.66%-95.94M	-11.72%-91.32M	8.71%-83.81M	14.51%-81.02M	34.98%-231.8M	137.05%36.53M
Net income discontinuous operations	----	----	----	--0	----	----	----	----	--0	----
Minority interest income
Net income attributable to the parent company	1,137.97%947.92M	-14.69%-96.12M	-0.66%-81.55M	-51.89%-352.09M	-362.66%-95.94M	-11.72%-91.32M	8.71%-83.81M	14.51%-81.02M	-114.44%-231.8M	138.60%36.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	1,137.97%947.92M	-14.69%-96.12M	-0.66%-81.55M	-51.89%-352.09M	-362.66%-95.94M	-11.72%-91.32M	8.71%-83.81M	14.51%-81.02M	-114.44%-231.8M	138.60%36.53M
Basic earnings per share	1,115.24%16.65	-11.92%-1.69	1.36%-1.45	-49.65%-6.33	-356.72%-1.72	-10.07%-1.64	10.12%-1.51	15.52%-1.47	-115.93%-4.23	138.51%0.67
Diluted earnings per share	1,089.02%16.22	-11.92%-1.69	1.36%-1.45	-49.65%-6.33	-356.72%-1.72	-10.07%-1.64	10.12%-1.51	15.52%-1.47	-115.93%-4.23	138.51%0.67
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data